The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use*; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007042:Hypoxanthines / Q000097:blood / Q000652:urine; D008297:Male; D008659:Metabolic Diseases / Q000188:drug therapy*; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood* / Q000652:urine*; D014528:Uricosuric Agents / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000188:drug therapy*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors; D014970:Xanthines / Q000097:blood / Q000652:urine
D007042:Hypoxanthines; D014528:Uricosuric Agents; D014970:Xanthines; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase